Recurrent mutations in the kinase domain of PIK3CA (exon 9 and 20) have been described in 13% of typical carcinoids and 39% of atypical carcinoids by means of Sanger sequencing [34]. This evidence concerns the gene PIK3CA and carcinoid tumor.